PAVmed share price logo

PAVmed

NASDAQ: PAVM

$5.28

+0.29

(+5.81%)

as on

PAVmed Stock Performance

as on September 3, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $5.03
    $5.65
    downward going graph

    4.73%

    Downside

    7.01%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $3.85
    $28.44
    downward going graph

    27.08%

    Downside

    438.64%

    Upside

    downward going graph

PAVmed share price movements today

Previous Close
$4.99
Open
$5.03
Volume
289.6K
Market Cap
$41.7M
Day's Low - High
$5.03 - $5.65
52 Week Low - High
$3.85 - $28.44

PAVmed Historical Returns

1 Month Return
+ 0.81 %
3 Month Return
-16.83 %
1 Year Return
-62.39 %
3 Year Return
-97.03 %
5 Year Return
-99.86 %

PAVmed Stock Fundamentals & Key Indicators

Check PAVmed market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$41.7M

EPS (TTM)

-37.69

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.29

Industry PE ratio

-1.4408823529411765

PEG Ratio

0.002267548547905255

EBITDA

-22.1M

Revenue (TTM)

85.0K

Profit Margin

-269.65%

Return On Equity TTM

-62.41%

PAVmed Stock Valuation

Track how PAVmed P/E has moved over time to understand its valuation trends.

PAVmed in the last 5 years

  • Overview

  • Trends

Lowest (-3.79x)

December 31, 2021

Industry (-1.44x)

December 31, 2025

Today (-1.18x)

December 31, 2025

Highest (0.19x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: -1.18x

PAVmed vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of PAVmed with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$41.7M-99.86%-0.29-269.65%NA
BUY$52.3B-24.77%53.277.98%NA
BUY$116.0B-31.69%24.1565.02%3.15%
BUY$124.2B14.3%32.6265.17%1.0999999999999999%
BUY$201.9B-15.22%35.7111.65%213.54999999999998%

Stock Returns calculator for PAVmed Stock including INR - Dollar returns

The PAVmed stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

PAVmed investment value today

Current value as on today

₹42,940

Returns

-₹57,060

(-57.06%)

Returns from PAVmed Stock

-₹60,208 (-60.21%)

Dollar Impact

₹3,148 (+3.15%)

Analyst Recommendation on PAVmed Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for PAVmed. Average target price of $36.5

PAVmed Share Price Target

Get share price movements and forecasts by analysts on PAVmed.

What analysts predicted

85.53%UPSIDE

Target Price

$36.5

Current Price

$5.28

Analyzed by

2 Analysts

Target

$36.50

PAVmed target price $36.5, a slight upside of 85.53% compared to current price of $5.28. According to 2 analysts rating.

Indian Investors' Interest in PAVmed Stock

Search interest for PAVmed Stock has decreased by -37% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-37% versus previous 30 day period

PAVmed Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
1
1
0
0
0
0
0
0
0
0
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-16
-14
-13
-11
-5
-5
-4
-4
-6
-8
EBITDA
-16
-17
-14
60
1
18
-12
-5
-2
-1
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-17
-18
-14
60
1
18
-12
-6
-2
-1
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-14
-15
-10
64
1
18
-11
-5
-1
0
Net Profit Margin
-53.57%
-72.67%
-101.33%
-38.65%
-380.00%
-887.50%
-583.33%
-1000.00%
-98.08%
-431.82%

PAVmed Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Mar 2019
Mar 2020
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
0
0
2
2
0
Gross Profit
0
0
0
-
0
-3
-3
-3
0
Operating Income
-8
-10
-14
-23
-54
-91
-68
-44
-21
EBITDA
-11
-12
-16
-23
-55
-99
-75
29
-2
Interest Expense
0
2
0
0
-
1
0
0
0
Depreciation
0
0
0
0
0
2
2
1
0
Income Before Tax
-9
-18
-17
-35
-56
-103
-79
28
-2
Income Tax Expense
-
-
-
-
-
-
-
-
-
Net Income
-9
-17
-15
-34
-50
-88
-64
39
0
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
-17.00%
-858.62%
-161.83%
-101.60%
-354.93%

PAVmed Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-17
-18
-14
60
1
18
-12
-6
-2
-1,064
Operating Cash Flow
-11
-13
-11
-8
0
-1
-1
0
-1
-2,620
Investing Cash Flow
0
0
0
-16
0
0
0
0
0
-22
Financing Cash Flow
5
19
11
0
0
3
2
0
-
7,564
Change in Cash
-6
5
0
-24
0
1
1
0
-1
4,922

PAVmed Annual Cash Flow

All numbers in Millions USD

Dec 2017
Mar 2019
Mar 2020
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-9
-18
-17
-35
-56
-103
-79
28
-2,469
Operating Cash Flow
-6
-8
-13
-21
-40
-70
-52
-33
-5,206
Investing Cash Flow
0
0
0
0
-3
-4
0
-16
-31
Financing Cash Flow
7
15
11
33
104
38
31
31
5,590
Change in Cash
0
6
-2
11
60
-37
-20
-18
353

Mutual Funds that own PAVmed Stock

Check out the Mutual Funds with significant holdings in PAVmed.

Funds
Holdings
Shares Held
Victory Portfolios III
0.111594%
8923
Fidelity Concord Street Trust
0.082166%
6570
VANGUARD INDEX FUNDS
0.074%
5917

Global Institutional Holdings in PAVmed

Funds
Holdings
Vanguard
0.77%
iShares
0.21%

Insights on PAVmed

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 22.0K → 33.0K (in $), with an average increase of 33.3% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Edwards Lifesciences Corp has given 18.8% return, outperforming this stock by 115.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Edwards Lifesciences Corp has given 11.7% return, outperforming this stock by 76.3%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 6 months, PAVM stock has moved down by -50.8%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -60.0K → -5.38M (in $), with an average decrease of 8873.3% per quarter

About PAVmed

PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck device. Its product pipeline also comprises EsoCure Esophageal Ablation Device for treating dysplastic BE; PortIO, an implantable intraosseous vascular access device; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.
OrganisationPAVmed
Headquarters360 Madison Avenue, New York, NY, United States, 10017
IndustryMedical Devices
CEODr. Lishan Aklog M.D.
E-voting on sharesClick here to vote

Key Management of PAVmed

Name

Title

Dr. Suman M. Verma M.D., Ph.D.

Senior VP of Molecular Genetics & Chief Scientific Officer

Mr. Matthew Riley

Senior Director of Investor Relations

Dr. Deepika A. Lakhani Ph.D.

Senior VP, Chief Regulatory & Quality Officer

Dr. Victoria T. Lee M.D.

Executive Vice President & Chief Medical Officer

Mr. Shaun M. O'Neill M.B.A.

Executive VP & COO

Mr. Michael Adam Gordon

Executive VP, General Counsel & Secretary

Dr. Brian J. deGuzman M.D.

Executive VP, Chief Technology & Compliance Officer

Dr. Lishan Aklog M.D.

Chairman & CEO

Mr. Joseph Virgilio

SVP & Chief Business Officer of Medical Devices

FAQs

What is PAVmed share price today?

PAVmed share price today is $5.28 as on at the close of the market. PAVmed share today touched a day high of $5.65 and a low of $5.03.

What is the 52 week high and 52 week low for PAVmed share?

PAVmed share touched a 52 week high of $28.44 on and a 52 week low of $3.85 on . PAVmed stock price today i.e. is closed at $5.28,which is 81.43% down from its 52 week high and 37.14% up from its 52 week low.

What is PAVmed's market capitalisation today?

PAVmed market capitalisation is $0.00T as on .

How to invest in PAVmed Stock (PAVM) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for PAVmed on INDmoney app. Click on Buy button. You can invest as low as $1.5 in PAVmed Shares that will get you 0.2841 shares as per PAVmed share price of $5.28 per share as on September 3, 2026 at 1:29 am IST.

What is the minimum amount required to buy PAVmed Stock (PAVM) from India?

Indian investors can start investing in PAVmed (PAVM) shares with as little as ₹94.96 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.60 in PAVmed stock (as per the Rupee-Dollar exchange rate as on ). Based on PAVmed share’s latest price of $5.28 as on September 3, 2026 at 1:29 am IST, you will get 1.8939 shares of PAVmed. Learn more about fractional shares .

What are the returns that PAVmed has given to Indian investors in the last 5 years?

PAVmed stock has given -99.86% share price returns and 30.36% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?